Objective: The objective of this study was to compare the cost-effectiveness of 3 strategies of serologic enzyme-linked immunosorbent assay (ELISA) testing and post-exposure varicella zoster immune globulin (VZIG) prophylaxis for the prevention of maternal varicella pneumonia during pregnancy in patients with negative or uncertain histories of varicella infection.
aricella (chickenpox) is a highly contagious viral illness usually acquired in childhood. Previous studies have shown that 90-95% of adults born in North America are serologically immune. While the disease is mild in childhood, it can cause significant morbidity in adults. In addition, these infections are believed to be especially severe during pregnancy because of alterations in the maternal immune status. Varicella infection in pregnancy has been associated with preterm labor, congenital malformations, and maternal pneumonia, z'3 Pneumonia is the most common complication in adults, with a mortality rate approaching 25%. While the actual number of cases of maternal varicella pneumonia is small, the severity of this disease warrants interventions and strategies for prevention. 
RESULTS
The baseline estimates, ranges, and references for the various probabilities used in the model are listed 
DISCUSSION
The clinical scenario in which a potentially susceptible pregnant woman is exposed to varicella is of great concern to both the patient and her physician. Questions about the long-term effectiveness of the vaccine in adults make this possibility speculative.
In summary, our study demonstrates that universal screening for varicella immunity followed by post-exposure treatment with VZIG in patients with negative or uncertain histories should not be performed. The choice between the other clinical strategies should be based on the availability of rapid serologic testing for varicella immunity.
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